Literature DB >> 29028661

Changes in viral suppression status among US HIV-infected patients receiving care.

Nicole Crepaz1, Tian Tang, Gary Marks, H Irene Hall.   

Abstract

OBJECTIVE: To examine changes in viral suppression status among HIV patients receiving care in 2014 and the extent of viral suppression among persons with infrequent care visits.
METHODS: Using data reported to the National HIV Surveillance System from 33 jurisdictions with complete reporting of CD4 and viral load tests, we created four viral suppression status groups based on their first and last viral loads in 2014: both suppressed, first unsuppressed and last suppressed (improved), first suppressed and last unsuppressed (worsened), and both unsuppressed. We also calculated the number and percentage of persons whose sole viral load in 2014 was suppressed and had a suppressed viral load at their last test in 2013.
RESULTS: Among 339 515 persons with at least two viral load tests in 2014, 72.6% had all viral loads suppressed (durably suppressed); 75.5% had the first and last tests suppressed, 10.5% improved, 4.2% worsened, and 9.9% had both unsuppressed. Among 92 309 persons who had only one viral load test in 2014, 69 960 (75.8%) were suppressed and, of those, 53 834 (76.9%) also had a suppressed viral load at their last test in 2013.
CONCLUSION: National surveillance data show that the majority of patients in HIV care during 2014 were durably suppressed. More showed improved compared with worsened viral suppression status. Some patients who have less frequent care visits have sustained viral suppression. Yet one in 10 who was in regular care did not have a suppressed viral load in 2014, indicating missed opportunities for clinical interventions to help patients achieve and sustain viral suppression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29028661     DOI: 10.1097/QAD.0000000000001660

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Effects of incentivizing viral suppression in previously incarcerated adults living with HIV.

Authors:  Forrest Toegel; August F Holtyn; Sarah Pollock; Andrew M Rodewald; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  HIV Res Clin Pract       Date:  2020-03-05

2.  Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers.

Authors:  Kathy K Byrd; John G Hou; Tim Bush; Ron Hazen; Heather Kirkham; Ambrose Delpino; Paul J Weidle; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Patrick G Clay
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

3.  A Comparative Analysis of Different HIV Viral Load Suppression Definitions Among Clients Receiving Care in the Miami-Dade Ryan White HIV/AIDS Program.

Authors:  Semiu O Gbadamosi; Mary Jo Trepka; Rahel Dawit; Zoran Bursac; Andrea Raymond; Robert A Ladner; Diana M Sheehan
Journal:  AIDS Behav       Date:  2022-05-10

4.  Better executive function is independently associated with full HIV suppression during combination therapy.

Authors:  Albert M Anderson; Josué Pérez-Santiago; Ziduo Zheng; Eugene Huang; Donald Franklin; Jennifer Iudicello; David J Moore; Ronald J Ellis; Robert K Heaton; Scott L Letendre
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.632

5.  Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.

Authors:  Margaret Johnson; Princy Kumar; Jean-Michel Molina; Giuliano Rizzardini; Pedro Cahn; Markus Bickel; Josep Mallolas; Yan Zhou; Cristiana Morais; Sushma Kumar; Peter Sklar; George J Hanna; Carey Hwang; Wayne Greaves
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

6.  Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White Program: the effect of demographic, psychosocial, provider and neighborhood factors.

Authors:  Diana M Sheehan; Rahel Dawit; Semiu O Gbadamosi; Kristopher P Fennie; Tan Li; Merhawi Gebrezgi; Petra Brock; Robert A Ladner; Mary Jo Trepka
Journal:  BMC Public Health       Date:  2020-03-13       Impact factor: 3.295

7.  Annual and durable HIV retention in care and viral suppression among patients of Peter Ho Clinic, 2013-2017.

Authors:  Debbie Y Mohammed; Lisa Marie Koumoulos; Eugene Martin; Jihad Slim
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

Review 8.  What we talk about when we talk about durable viral suppression.

Authors:  Karen Diepstra; Haidong Lu; Kathleen A McManus; Elizabeth T Rogawski McQuade; Anne G Rhodes; Daniel Westreich
Journal:  AIDS       Date:  2020-09-01       Impact factor: 4.632

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.